FASN and fatty liver disease: Consistent with our data, the liver-specific Scd1 knockout (KO) mice are protected from obesity-induced hepatic steatosis, while exhibiting reduced rates of hepatic fatty acid synthesis and decreased expression of key lipogenic enzymes (Fasn and Acc1/2) [48].